The Seed Investor
Early Stage Investing
Join our Newsletter  Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)
  •  
  • Cannabis News
  • Marijuana Industry
  • Marijuana Investing
  • Psychedelics
  • Featured Companies
  • TSI Exclusive
  • About
    • Overview
    • Disclaimer
    • Advertise
    • Privacy Policy

Trending Now

  • MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies
  • Mind Cure Establishes Psychedelic Compound Research Program
  • Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
  • MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
  • Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization
  • Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger
Psychedelic Stocks
Exploring the companies and themes that make up this emerging and exciting new sector

Field Trip Health Ltd. Continues Expansion With Psychedelic-Enhanced Therapy Center in Chicago

2020-10-22 PSW Editor

Field Trip Health opens a new clinic in Chicago, its 4th ketamine-assisted psychotherapy clinic.

Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms

2020-10-22 PSW Editor

Numinus announces its first psilocybin harvest and the appointment of a new Science Officer.

Mind Cure’s New Medtech Platform Is A Critical Puzzle-Piece

2020-10-21 Jeff Nielson

With its new digital therapeutics platform, Mind Cure is positioning itself as an emerging leader in the psychedelic drug industry.

Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds

2020-10-20 PSW Editor

Revive has signed a psychedelics supply agreement with HAVN Life Sciences.

Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson's Disease

2020-10-20 PSW Editor

Pharmather is seeking to advance a ketamine-based therapy for the treatment of Parkinson's disease.

Will MindMed NASDAQ Listing Be The Next Sector-Wide Catalyst?

2020-10-19 Jeff Nielson

The Compass Pathways IPO was a huge catalyst for the whole sector. Will a MindMed up-listing have the same impact?

Cybin and Clarmin Announce Closing of CDN$45 Million Oversubscribed Private Placement and Provide Update on RTO

2020-10-19 PSW Editor

Cybin Corp. announces it has closed on an oversubscribed private placement of CAD$45 million as it prepares to go public.

How Medtech Is Taking Healthcare Into The 21st Century

2020-10-16 Jeff Nielson

What is medtech? It's the wave of the future for healthcare.

Mydecine Innovations Group Appoints Boustead Capital Markets LLP as Financial Advisor for its Planned Dual Listing on the London Stock Exchange

2020-10-16 PSW Editor

Mydecine begins the dual listing process to obtain an LSE listing.

The 8 Best Reasons To Invest In Psychedelic Stocks

2020-10-15 Jeff Nielson

Acute need. Huge markets. A wide-open playing field. Those are some of the best reasons to invest in psychedelic drug stocks.

Mind Cure Health : Announces Geoff Belair as Chief Technology Officer

2020-10-15 PSW Editor

Mind Cure brings in an expert in fintech to be its new CTO.

Numinus (CSE:NUMI) or Mydecine (CSE:MYCO)? Two Psychedelics Investing Options

2020-10-14 Jeff Nielson

Both Numinus and Mydecine have been rising recently on big volume. Which is the better bet?

  • Previous
  • 1
  • ...
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • ...
  • 72
  • Next
Join our Newsletter
 Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)

The Seed Investor Exclusive

MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies

MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies

2021-01-21
Mind Cure announces a CAD$10 million bought deal financing at a unit price of CAD$0.60. Proceeds will be directed toward product research development and related tech initiatives like its iSTRYM digital therapeutics platform.

Mind Cure Establishes Psychedelic Compound Research Program

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research

Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD

Psychedelic Stocks
NEWS
INDUSTRY
INVESTING
COMPANIES
EXCLUSIVE

Newsletter

Get The Seed Investor straight to your email.

Copyright © 2016-2022, The Seed Investor | About | Contact | Advertise | Privacy Policy | Disclaimer
Powered by StructureCMS
The Seed Investor